Guaranteeing resilience in vaccine manufacturing
European Pharmaceutical Review
SEPTEMBER 28, 2023
When questioned about which technologies he considered have potential to advance the sector, Chornet emphasised that not only is mRNA as a vaccine technology “a very promising and interesting platform [but that it is] disruptive and a game changer technology for vaccine [manufacturing] and overall biotech.”
Let's personalize your content